NATIONAL INSTITUTES OF HEALTH has floated a tender for Phs 2023-2 Omnibus Solicitation of the Nih and Cdc for Small Business Innovation Research Grant Applications (Parent Sbir [R43/R44] Clinical Trial Required). The project location is USA and the tender is closing on 05 Apr 2024. The tender notice number is PA-23-231, while the TOT Ref Number is 85625842. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : USA

Summary : Phs 2023-2 Omnibus Solicitation of the Nih and Cdc for Small Business Innovation Research Grant Applications (Parent Sbir [R43/R44] Clinical Trial Required)

Deadline : 05 Apr 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 85625842

Document Ref. No. : PA-23-231

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Purchaser : NATIONAL INSTITUTES OF HEALTH
NIH Grants Informationgrantsinfo@nih.gov
USA
Email :grantsinfo@nih.gov

Tender Details

Tender are invited for PHS 2023-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
CFDA Number : 93.361 -- Nursing Research93.394 -- Cancer Detection and Diagnosis Research93.395 -- Cancer Treatment Research93.867 -- Vision Research
Cost Sharing or Matching Requirement : No
Closing Date for Applications: Apr 05, 2024
Posted Date : Jul 12, 2023
Description: This Notice of Funding Opportunity Announcement (NOFO), issued by the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) invites eligible United States small businesses to submit Small Business Innovation Research (SBIR) grant applications. United States small businesses that have the research capabilities and technological expertise to contribute to the R and D mission(s) of the NIH and CDC awarding components identified in this NOFO are encouraged to submit SBIR grant applications in response to identified topics (see PHS 2022-2 SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA).This Parent Funding Opportunity Announcement requires that at least 1 clinical trial be proposed. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions.

Documents

 Tender Notice

PA-23-231-Full-Announcement--PA-23-231.zip